Available IPD datapackage for study 'A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MSTT1041A or UTTR1147A in Patients With Severe COVID-19 Pneumonia'
收藏DataCite Commons2025-03-26 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00005961.3
下载链接
链接失效反馈官方服务：
资源简介：
This is a Phase II, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of MSTT1041A (astegolimab) or UTTR1147A in combination with standard of care (SOC) compared with matching placebo in combination with SOC in patients hospitalized with severe coronavirus disease 2019 (COVID-19) pneumonia.
提供机构：
Vivli
创建时间：
2025-03-26
